These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 3423390)

  • 1. Binding of 3-carbethoxipsoralen to human serum albumin and human serum: influence of free fatty acids.
    Font G; Mañes J; Martre H; Prognon P; Mahuzier G
    Rev Esp Fisiol; 1987 Sep; 43(3):317-21. PubMed ID: 3423390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-protein interaction: plasma protein binding of furocoumarins.
    Veronese FM; Bevilacqua R; Schiavon O; Rodighiero G
    Farmaco Sci; 1979 Aug; 34(8):716-25. PubMed ID: 467637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of 5-methoxypsoralen to blood fractions. Influence of albumin and free fatty acids: an in vitro study.
    Muret P; Makki S; Urien S; Agache P; Bechtel P; Tillement JP
    Skin Pharmacol; 1993; 6(1):45-51. PubMed ID: 7683892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum protein binding of valproic acid in healthy subjects and in patients with liver disease.
    Urien S; Albengres E; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):319-25. PubMed ID: 6790449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of urapidil to human serum albumin: dependency on free fatty acid concentration.
    Storck J; Kirsten R
    Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):204-8. PubMed ID: 2071271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma protein binding of metbufen, a new non-steroid anti-inflammatory drug, in humans.
    Brunner F; Zini R; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):134-9. PubMed ID: 6201451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Method dependence of apparent stoichiometry in the binding of salicylate ion to human serum albumin: a comparison between equilibrium dialysis and fluorescence titration.
    Ozer I; Tacal O
    Anal Biochem; 2001 Jul; 294(1):1-6. PubMed ID: 11411999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of bornaprolol to human serum proteins and blood cells.
    Shastri RA; Barre J; Houin G; Hamberger C; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):351-6. PubMed ID: 3733286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro binding study of gemfibrozil to human serum proteins and erythrocytes: interactions with other drugs.
    Hamberger C; Barre J; Zini R; Taiclet A; Houin G; Tillement JP
    Int J Clin Pharmacol Res; 1986; 6(6):441-9. PubMed ID: 3468088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefazolin serum protein binding and its inhibition by bilirubin, fatty acids and other drugs.
    Decroix MO; Zini R; Chaumeil JC; Tillement JP
    Biochem Pharmacol; 1988 Jul; 37(14):2807-14. PubMed ID: 3395358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of serum protein binding of felodipine.
    Valle M; Esteban M; Rodríguez-Sasiaín JM; Calvo R; Aguirre C
    Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):73-88. PubMed ID: 8948016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progabide and SL 75102 binding to plasma proteins and red blood cells in humans.
    Hamberger C; Barre J; Brandebourger M; Urien S; Taiclet A; Thenot JP; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):178-84. PubMed ID: 3583466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma cotisosterone-albumin binding and role of fatty acids in the determination of the parameters of binding of this protein in the rat].
    Koch B; Lutz B; Mialhe-Voloss C; Stutinsky F
    Horm Metab Res; 1969 Jul; 1(4):183-6. PubMed ID: 5408730
    [No Abstract]   [Full Text] [Related]  

  • 14. Propofol binding to human blood proteins.
    Altmayer P; Büch U; Büch HP
    Arzneimittelforschung; 1995 Oct; 45(10):1053-6. PubMed ID: 8595056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
    Nishio T; Takamura N; Nishii R; Tokunaga J; Yoshimoto M; Kawai K
    Nephrol Dial Transplant; 2008 Jul; 23(7):2304-10. PubMed ID: 18390890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of free fatty acid concentration on the transport and utilization of other albumin-bound compounds: hydroxyphenylazobenzoic acid.
    Spector AA; Imig B
    Mol Pharmacol; 1971 Sep; 7(5):511-8. PubMed ID: 5139562
    [No Abstract]   [Full Text] [Related]  

  • 17. Dosage plan of a flurbiprofen injection product using inhibition of protein binding by lipid emulsion in rats.
    Ogata K; Takamura N; Tokunaga J; Kawai K; Arimori K; Higuchi S
    J Pharm Pharmacol; 2008 Jan; 60(1):15-20. PubMed ID: 18088500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of two anthranilic acid derivatives to human albumin, erythrocytes, and lipoproteins: evidence for glafenic acid high affinity binding.
    Albengres E; Urien S; Riant P; Marcel GA; Tillement JP
    Mol Pharmacol; 1987 Mar; 31(3):294-300. PubMed ID: 2882410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
    Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
    J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro study on the competitive binding of diflunisal and uraemic toxins to serum albumin and human plasma using a potentiometric ion-probe technique.
    Davilas A; Koupparis M; Macheras P; Valsami G
    J Pharm Pharmacol; 2006 Nov; 58(11):1467-74. PubMed ID: 17132209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.